Home2022November (Page 50)

S&P 500 3,965.34 +18.78(+0.48%)   Dow 30 33,745.69 +199.37(+0.59%)   Nasdaq 11,146.06 +1.10(+0.01%)   Russell 2000 1,849.73 +10.61(+0.58%)   Crude Oil 80.11 -1.53(-1.87%)   Gold 1,752.00 -11.00(-0.62%)   Silver 20.98 0.00(0.00%)   EUR/USD 1.0320 -0.0046(-0.44%)   10-Yr Bond 3.8180 +0.0430(+1.14%)   GBP/USD 1.1896 +0.0030(+0.25%)   USD/JPY 140.3600 +0.1140(+0.08%)   BTC-USD 16,686.29 +56.69(+0.34%)   CMC Crypto 200 388.37 -3.71(-0.95%)   FTSE 100 7,385.52 +38.98(+0.53%)   Nikkei 225 27,899.77 -30.80(-0.11%)   (Bloomberg) -- On the most optimistic corners of Wall Street, promising inflation data over the past week or so suggest the Federal Reserve may accomplish a soft landing after all. Most Read from Bloomberg Malaysia Latest: Tight Election

S&P 500 3,965.34 +18.78(+0.48%)   Dow 30 33,745.69 +199.37(+0.59%)   Nasdaq 11,146.06 +1.10(+0.01%)   Russell 2000 1,849.73 +10.61(+0.58%)   Crude Oil 80.11 -1.53(-1.87%)   Gold 1,752.00 -11.00(-0.62%)   Silver 20.98 0.00(0.00%)   EUR/USD 1.0320 -0.0046(-0.44%)   10-Yr Bond 3.8180 +0.0430(+1.14%)   GBP/USD 1.1896 +0.0030(+0.25%)   USD/JPY 140.3600 +0.1140(+0.08%)   BTC-USD 16,710.18 +67.42(+0.41%)   CMC Crypto 200 388.37 -3.71(-0.95%)   FTSE 100 7,385.52 +38.98(+0.53%)   Nikkei 225 27,899.77 -30.80(-0.11%)   U.S. home prices could tumble as much as 20% as the highest mortgage rates in two decades threaten to trigger a "severe" price correction, according to research from the Federal Reserve Bank of Dallas. Fed policymakers need

S&P 500 3,965.34 +18.78(+0.48%)   Dow 30 33,745.69 +199.37(+0.59%)   Nasdaq 11,146.06 +1.10(+0.01%)   Russell 2000 1,849.73 +10.61(+0.58%)   Crude Oil 80.11 -1.53(-1.87%)   Gold 1,752.00 -11.00(-0.62%)   Silver 20.98 0.00(0.00%)   EUR/USD 1.0320 -0.0046(-0.44%)   10-Yr Bond 3.8180 +0.0430(+1.14%)   GBP/USD 1.1896 +0.0030(+0.25%)   USD/JPY 140.3600 +0.1140(+0.08%)   BTC-USD 16,752.44 +95.86(+0.58%)   CMC Crypto 200 388.37 -3.71(-0.95%)   FTSE 100 7,385.52 +38.98(+0.53%)   Nikkei 225 27,899.77 -30.80(-0.11%)   Medicare Part B documents The surprisingly big jump in Medicare Part B premiums for 2022 reflects the sky-high cost of a controversial Alzheimer’s disease drug. The premium hike will put more than a dent in the newly increased